In the first episode of a three-part series, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss recently issued updates to breast cancer screening recommendations from the American College of Radiology and the United States Preventive Services Task Force and potential implications for health equity.
On the latest episode of The Reading Room podcast, Anand Narayan, M.D., and Amy Patel, M.D., offer their perspectives and insights on the possible impact of recent breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF) and the American College of Radiology (ACR).
(Editor's note: For related content, see "The Reading Room: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 2" and "The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3.")
Listen below or subscribe on your favorite podcast platform.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.